Andra AP fonden Raises Stake in STERIS plc $STE

Andra AP fonden grew its holdings in shares of STERIS plc (NYSE:STE) by 854.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,800 shares of the medical equipment provider’s stock after purchasing an additional 41,000 shares during the quarter. Andra AP fonden’s holdings in STERIS were worth $11,333,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in STE. Steigerwald Gordon & Koch Inc. acquired a new position in shares of STERIS in the 3rd quarter valued at about $25,000. Spurstone Advisory Services LLC acquired a new stake in shares of STERIS during the second quarter worth $29,000. Cloud Capital Management LLC bought a new position in STERIS during the 3rd quarter worth $29,000. Geneos Wealth Management Inc. raised its position in shares of STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares in the last quarter. Finally, TruNorth Capital Management LLC bought a new position in shares of STERIS during the 3rd quarter valued at about $37,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Down 0.9%

STERIS stock opened at $252.36 on Friday. The business’s 50-day simple moving average is $255.83 and its 200-day simple moving average is $251.68. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44. The firm has a market capitalization of $24.75 billion, a PE ratio of 35.20 and a beta of 1.03. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same period in the prior year, the company posted $2.32 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities research analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio is currently 35.15%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on STE shares. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.